News & Events

The newest edition of our webinar series will explore the various criteria to consider when starting the selection process of a Contract Development and Manufacturing Organization (CDMO)! Join our 25 November session to learn everything you need to know about CDMO selection with two highly-qualified experts from company Naobios, Eric LE FORESTIER (CEO) and Luís RAIADO (Head of Business Development). Naobios is a CDMO with extensive experience through diverse background in biopharma development and manufacturing.

Whenever you need to outsource a project, you want to be sure that you are making the right choice regarding your CDMO. Indeed, this will be a partnership for the whole lifetime of a project, which can be a bumpy road! In this webinar, we will go over the different aspects you will need to consider during the selection process of your CDMO.

Since this is a partnership, we will also bring you to the other side of the mirror and show you what is the point of view of the CDMO – and the expectations such organization may have regarding a project.

Through this presentation, we hope that you will be better prepared to start this new and exciting aventure – potentially with us! 

Eric LEFORESTIER
He is Managing Director at Naobios,bringing 20 years of international experience across the Biotech and Pharmaceutical Industry. Prior to joining Naobios, Eric spent 12 years with GSK Vaccines; his last position was Head of infrastructure of the QC laboratories in Belgium. Eric has also worked with Aquitaine Pharm International,a CMO specialized in aseptic fill and finish of highly potent APIs, previously part of Pierre Fabre Laboratories; and Immuno-Design Molecules,a Biotech company developing cellular therapies against cancer, now part of Takeda Oncology. Eric has lived and worked in France, the UK, the US, Belgium and Japan. He holds a PharmD in Industrial Pharmacy from Nantes University, an MS in IT applied to Life
Sciences from Paris University and a Global Executive MBA from INSEAD.

 

Luís RAIADO
He holds a PhD in biotechnology focusing on downstream process development, and particularly for the purification of plasmid DNA for vaccines and gene therapy, where he published several scientific papers with relevant impact. As a post-doc researcher, he also worked on development of downstream processes for several other biological entities, such as virus-like particles (VLPs), viral vectors and proteins. In 2020, after 4 years as a business developer in the biosafety testing field, he joins Naobios as business development manager.

 

Looking forward to seeing you on November 25^th, 2021 at 4pm for this new webinar.
>> Follow the link to register to the event: https://bit.ly/3o09Vqi